D-1113-2019 Class II Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-1113-2019 was initiated by LUPIN SOMERSET on Mar 19, 2019 and is designated Class II. Reason for recall: Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient The recall status is terminated (terminated May 23, 2022). Affected quantity: 76422 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2019
Initiation Date
Mar 19, 2019
Termination Date
May 23, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
76422 bottles

Product description

Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034

Reason for recall

Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Distribution pattern

Nationwide

Code information

Lot #: a) S800021, Exp 30-Nov-20; b) S800175, Exp 31-Dec-20; c) S 800401, Exp 28-Feb-21; S800426, Exp 31-Mar-21; S800920, Exp 31-Aug-21.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1113-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1113-2019. Report a data issue: hello@regdatalab.com.